# The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025, Regulation 17: Amendment of regulation 19C


In regulation 19C (fees for assessment of post-authorisation safety studies) for “£9,140”, in both places it occurs, substitute “£9,949”.

---
Source: https://www.legislation.gov.uk/uksi/2025/317/regulation/17 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-2025/regulation-17
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.